Annual CFO:
-$108.56M-$64.68M(-147.41%)Summary
- As of today, ABCL annual cash from operations is -$108.56 million, with the most recent change of -$64.68 million (-147.41%) on December 31, 2024.
- During the last 3 years, ABCL annual cash from operations has fallen by -$353.14 million (-144.38%).
- ABCL annual cash from operations is now -139.14% below its all-time high of $277.36 million, reached on December 31, 2022.
Performance
ABCL Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$33.21M-$21.65M(-187.40%)Summary
- As of today, ABCL quarterly cash from operations is -$33.21 million, with the most recent change of -$21.65 million (-187.40%) on June 1, 2025.
- Over the past year, ABCL quarterly cash from operations has dropped by -$3.75 million (-12.72%).
- ABCL quarterly cash from operations is now -112.23% below its all-time high of $271.51 million, reached on June 30, 2022.
Performance
ABCL Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$79.94M-$3.75M(-4.92%)Summary
- As of today, ABCL TTM cash from operations is -$79.94 million, with the most recent change of -$3.75 million (-4.92%) on June 1, 2025.
- Over the past year, ABCL TTM cash from operations has increased by +$10.46 million (+11.57%).
- ABCL TTM cash from operations is now -123.26% below its all-time high of $343.60 million, reached on June 30, 2022.
Performance
ABCL TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ABCL Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -147.4% | -12.7% | +11.6% |
| 3Y3 Years | -144.4% | -112.2% | -123.3% |
| 5Y5 Years | -4129.6% | -227.8% | -462.2% |
ABCL Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -139.1% | at low | -239.0% | +74.4% | -130.1% | +38.5% |
| 5Y | 5-Year | -139.1% | at low | -112.2% | +74.4% | -123.3% | +38.5% |
| All-Time | All-Time | -139.1% | at low | -112.2% | +74.4% | -123.3% | +38.5% |
ABCL Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$33.21M(-187.4%) | -$79.94M(-4.9%) |
| Mar 2025 | - | -$11.55M(-86.9%) | -$76.19M(+28.4%) |
| Dec 2024 | -$108.56M(-147.4%) | -$6.18M(+78.7%) | -$106.34M(+10.8%) |
| Sep 2024 | - | -$29.00M(+1.6%) | -$119.28M(-31.9%) |
| Jun 2024 | - | -$29.46M(+29.4%) | -$90.40M(-119.8%) |
| Mar 2024 | - | -$41.71M(-118.2%) | -$41.12M(+5.4%) |
| Dec 2023 | -$43.88M(-115.8%) | -$19.11M(>-9900.0%) | -$43.48M(-8900.2%) |
| Sep 2023 | - | -$122.60K(-100.6%) | -$483.10K(+99.6%) |
| Jun 2023 | - | $19.82M(+145.0%) | -$130.01M(-206.8%) |
| Mar 2023 | - | -$44.06M(-284.5%) | $121.69M(-54.2%) |
| Dec 2022 | $277.36M | $23.88M(+118.4%) | $265.97M(+18.1%) |
| Sep 2022 | - | -$129.65M(-147.8%) | $225.20M(-34.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $271.51M(+170.9%) | $343.60M(+46.9%) |
| Mar 2022 | - | $100.22M(+693.7%) | $233.93M(-3.8%) |
| Dec 2021 | $244.58M(+977.9%) | -$16.88M(-50.1%) | $243.25M(-7.1%) |
| Sep 2021 | - | -$11.25M(-107.0%) | $261.78M(-3.0%) |
| Jun 2021 | - | $161.83M(+47.7%) | $269.89M(+101.4%) |
| Mar 2021 | - | $109.55M(+6526.2%) | $134.03M(+465.0%) |
| Dec 2020 | $22.69M(+742.2%) | $1.65M(+152.6%) | $23.72M(+7.5%) |
| Sep 2020 | - | -$3.14M(-112.1%) | $22.07M(-12.5%) |
| Jun 2020 | - | $25.98M(+3500.1%) | $25.21M(+3400.1%) |
| Mar 2020 | - | -$764.00K | -$764.00K |
| Dec 2019 | $2.69M(-24.4%) | - | - |
| Dec 2018 | $3.56M | - | - |
FAQ
- What is AbCellera Biologics Inc. annual cash from operations?
- What is the all-time high annual cash from operations for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. annual cash from operations year-on-year change?
- What is AbCellera Biologics Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. quarterly cash from operations year-on-year change?
- What is AbCellera Biologics Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. TTM cash from operations year-on-year change?
What is AbCellera Biologics Inc. annual cash from operations?
The current annual cash from operations of ABCL is -$108.56M
What is the all-time high annual cash from operations for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high annual cash from operations is $277.36M
What is AbCellera Biologics Inc. annual cash from operations year-on-year change?
Over the past year, ABCL annual cash from operations has changed by -$64.68M (-147.41%)
What is AbCellera Biologics Inc. quarterly cash from operations?
The current quarterly cash from operations of ABCL is -$33.21M
What is the all-time high quarterly cash from operations for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high quarterly cash from operations is $271.51M
What is AbCellera Biologics Inc. quarterly cash from operations year-on-year change?
Over the past year, ABCL quarterly cash from operations has changed by -$3.75M (-12.72%)
What is AbCellera Biologics Inc. TTM cash from operations?
The current TTM cash from operations of ABCL is -$79.94M
What is the all-time high TTM cash from operations for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high TTM cash from operations is $343.60M
What is AbCellera Biologics Inc. TTM cash from operations year-on-year change?
Over the past year, ABCL TTM cash from operations has changed by +$10.46M (+11.57%)